BioCryst Pharmaceuticals, Inc. (BCRX)
USD 6.8
(-7.23%)
USD 6.8
(-7.23%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 972.48 Million USD | 15.14% |
| 2022 | 844.59 Million USD | 21.5% |
| 2021 | 695.13 Million USD | 96.38% |
| 2020 | 353.97 Million USD | 158.32% |
| 2019 | 137.03 Million USD | 40.39% |
| 2018 | 97.6 Million USD | 3.3% |
| 2017 | 94.49 Million USD | 7.05% |
| 2016 | 88.26 Million USD | 14.89% |
| 2015 | 76.83 Million USD | 25.46% |
| 2014 | 61.23 Million USD | 22.5% |
| 2013 | 49.99 Million USD | -13.65% |
| 2012 | 57.89 Million USD | -14.11% |
| 2011 | 67.4 Million USD | 53.38% |
| 2010 | 43.94 Million USD | -21.42% |
| 2009 | 55.92 Million USD | 46.15% |
| 2008 | 38.26 Million USD | -50.82% |
| 2007 | 77.81 Million USD | 64.4% |
| 2006 | 47.33 Million USD | 15.98% |
| 2005 | 40.8 Million USD | 1201.96% |
| 2004 | 3.13 Million USD | 90.08% |
| 2003 | 1.64 Million USD | 40.63% |
| 2002 | 1.17 Million USD | -48.63% |
| 2001 | 2.28 Million USD | -75.58% |
| 2000 | 9.34 Million USD | 367.27% |
| 1999 | 2 Million USD | 42.86% |
| 1998 | 1.4 Million USD | 16.67% |
| 1997 | 1.2 Million USD | -29.41% |
| 1996 | 1.7 Million USD | -5.56% |
| 1995 | 1.8 Million USD | 12.5% |
| 1994 | 1.6 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 944.05 Million USD | -2.92% |
| 2024 Q2 | 948.02 Million USD | 0.42% |
| 2024 Q3 | 959.81 Million USD | 1.24% |
| 2023 Q1 | 838.02 Million USD | -0.78% |
| 2023 Q3 | 933.91 Million USD | 1.67% |
| 2023 Q2 | 918.59 Million USD | 9.61% |
| 2023 FY | 972.48 Million USD | 15.14% |
| 2023 Q4 | 972.48 Million USD | 4.13% |
| 2022 Q4 | 844.59 Million USD | 5.41% |
| 2022 FY | 844.59 Million USD | 21.5% |
| 2022 Q2 | 723.77 Million USD | 4.6% |
| 2022 Q3 | 801.25 Million USD | 10.71% |
| 2022 Q1 | 691.93 Million USD | -0.46% |
| 2021 FY | 695.13 Million USD | 96.38% |
| 2021 Q1 | 359.41 Million USD | 1.54% |
| 2021 Q2 | 383.35 Million USD | 6.66% |
| 2021 Q3 | 412.8 Million USD | 7.68% |
| 2021 Q4 | 695.13 Million USD | 68.39% |
| 2020 Q2 | 138.19 Million USD | 3.96% |
| 2020 FY | 353.97 Million USD | 158.32% |
| 2020 Q1 | 132.94 Million USD | -2.98% |
| 2020 Q3 | 142.58 Million USD | 3.18% |
| 2020 Q4 | 353.97 Million USD | 148.25% |
| 2019 FY | 137.03 Million USD | 40.39% |
| 2019 Q2 | 125.53 Million USD | 4.76% |
| 2019 Q3 | 131.75 Million USD | 4.95% |
| 2019 Q4 | 137.03 Million USD | 4.01% |
| 2019 Q1 | 119.83 Million USD | 22.77% |
| 2018 Q3 | 95.43 Million USD | 5.5% |
| 2018 FY | 97.6 Million USD | 3.3% |
| 2018 Q4 | 97.6 Million USD | 2.27% |
| 2018 Q2 | 90.46 Million USD | -3.06% |
| 2018 Q1 | 93.31 Million USD | -1.24% |
| 2017 FY | 94.49 Million USD | 7.05% |
| 2017 Q4 | 94.49 Million USD | 4.0% |
| 2017 Q3 | 90.86 Million USD | 1.6% |
| 2017 Q2 | 89.43 Million USD | -1.7% |
| 2017 Q1 | 90.98 Million USD | 3.07% |
| 2016 Q4 | 88.26 Million USD | 0.87% |
| 2016 FY | 88.26 Million USD | 14.89% |
| 2016 Q2 | 68.83 Million USD | -8.33% |
| 2016 Q3 | 87.5 Million USD | 27.14% |
| 2016 Q1 | 75.08 Million USD | -2.28% |
| 2015 FY | 76.83 Million USD | 25.46% |
| 2015 Q1 | 65.49 Million USD | 6.95% |
| 2015 Q3 | 74.91 Million USD | 1.11% |
| 2015 Q2 | 74.09 Million USD | 13.12% |
| 2015 Q4 | 76.83 Million USD | 2.56% |
| 2014 Q3 | 53.67 Million USD | 3.44% |
| 2014 FY | 61.23 Million USD | 22.5% |
| 2014 Q2 | 51.88 Million USD | 5.65% |
| 2014 Q1 | 49.11 Million USD | -1.76% |
| 2014 Q4 | 61.23 Million USD | 14.1% |
| 2013 Q3 | 49.79 Million USD | 1.7% |
| 2013 Q4 | 49.99 Million USD | 0.4% |
| 2013 Q2 | 48.96 Million USD | -1.56% |
| 2013 Q1 | 49.73 Million USD | -14.08% |
| 2013 FY | 49.99 Million USD | -13.65% |
| 2012 Q1 | 56.93 Million USD | -15.53% |
| 2012 Q2 | 60.57 Million USD | 6.4% |
| 2012 Q3 | 54.31 Million USD | -10.35% |
| 2012 Q4 | 57.89 Million USD | 6.6% |
| 2012 FY | 57.89 Million USD | -14.11% |
| 2011 Q1 | 68.59 Million USD | 56.1% |
| 2011 Q2 | 69.14 Million USD | 0.8% |
| 2011 FY | 67.4 Million USD | 53.38% |
| 2011 Q3 | 66.46 Million USD | -3.87% |
| 2011 Q4 | 67.4 Million USD | 1.4% |
| 2010 Q2 | 32.49 Million USD | -16.95% |
| 2010 FY | 43.94 Million USD | -21.42% |
| 2010 Q1 | 39.12 Million USD | -30.03% |
| 2010 Q4 | 43.94 Million USD | 18.75% |
| 2010 Q3 | 37 Million USD | 13.88% |
| 2009 Q2 | 33.4 Million USD | -1.98% |
| 2009 FY | 55.92 Million USD | 46.15% |
| 2009 Q3 | 37.04 Million USD | 10.88% |
| 2009 Q4 | 55.92 Million USD | 50.97% |
| 2009 Q1 | 34.08 Million USD | -10.92% |
| 2008 Q4 | 38.26 Million USD | -40.53% |
| 2008 FY | 38.26 Million USD | -50.82% |
| 2008 Q1 | 74.92 Million USD | -3.72% |
| 2008 Q2 | 65.22 Million USD | -12.94% |
| 2008 Q3 | 64.34 Million USD | -1.35% |
| 2007 Q2 | 69.08 Million USD | 28.11% |
| 2007 Q1 | 53.92 Million USD | 13.93% |
| 2007 FY | 77.81 Million USD | 64.4% |
| 2007 Q4 | 77.81 Million USD | 3.0% |
| 2007 Q3 | 75.54 Million USD | 9.35% |
| 2006 FY | 47.33 Million USD | 15.98% |
| 2006 Q4 | 47.33 Million USD | -5.67% |
| 2006 Q1 | 49 Million USD | 20.08% |
| 2006 Q2 | 47.48 Million USD | -3.1% |
| 2006 Q3 | 50.17 Million USD | 5.66% |
| 2005 Q2 | 2.56 Million USD | -14.15% |
| 2005 Q4 | 40.8 Million USD | 989.08% |
| 2005 FY | 40.8 Million USD | 1201.96% |
| 2005 Q1 | 2.98 Million USD | -4.83% |
| 2005 Q3 | 3.74 Million USD | 46.31% |
| 2004 FY | 3.13 Million USD | 90.08% |
| 2004 Q1 | 2.52 Million USD | 53.12% |
| 2004 Q4 | 3.13 Million USD | -12.15% |
| 2004 Q2 | 2.35 Million USD | -6.61% |
| 2004 Q3 | 3.56 Million USD | 51.31% |
| 2003 Q4 | 1.64 Million USD | 15.23% |
| 2003 Q3 | 1.43 Million USD | -9.72% |
| 2003 Q2 | 1.58 Million USD | 33.53% |
| 2003 Q1 | 1.18 Million USD | 1.23% |
| 2003 FY | 1.64 Million USD | 40.63% |
| 2002 Q2 | 1.66 Million USD | -9.26% |
| 2002 FY | 1.17 Million USD | -48.63% |
| 2002 Q3 | 1.23 Million USD | -25.89% |
| 2002 Q1 | 1.83 Million USD | -19.61% |
| 2002 Q4 | 1.17 Million USD | -4.98% |
| 2001 Q2 | 4.39 Million USD | -44.44% |
| 2001 FY | 2.28 Million USD | -75.58% |
| 2001 Q3 | 1.1 Million USD | -74.99% |
| 2001 Q4 | 2.28 Million USD | 107.51% |
| 2001 Q1 | 7.91 Million USD | -15.3% |
| 2000 Q3 | 1.23 Million USD | -32.42% |
| 2000 Q4 | 9.34 Million USD | 658.56% |
| 2000 Q1 | 1.6 Million USD | -19.71% |
| 2000 FY | 9.34 Million USD | 367.27% |
| 2000 Q2 | 1.82 Million USD | 13.53% |
| 1999 Q4 | 2 Million USD | 33.33% |
| 1999 FY | 2 Million USD | 42.86% |
| 1999 Q1 | 1.3 Million USD | -7.14% |
| 1999 Q2 | 1.3 Million USD | 0.0% |
| 1999 Q3 | 1.5 Million USD | 15.38% |
| 1998 FY | 1.4 Million USD | 16.67% |
| 1998 Q1 | 1.7 Million USD | 41.67% |
| 1998 Q2 | 1.5 Million USD | -11.76% |
| 1998 Q3 | 1.8 Million USD | 20.0% |
| 1998 Q4 | 1.4 Million USD | -22.22% |
| 1997 Q2 | 1.8 Million USD | 5.88% |
| 1997 Q4 | 1.2 Million USD | -25.0% |
| 1997 Q3 | 1.6 Million USD | -11.11% |
| 1997 Q1 | 1.7 Million USD | 0.0% |
| 1997 FY | 1.2 Million USD | -29.41% |
| 1996 Q3 | 1.6 Million USD | -15.79% |
| 1996 Q2 | 1.9 Million USD | 18.75% |
| 1996 Q1 | 1.6 Million USD | -11.11% |
| 1996 Q4 | 1.7 Million USD | 6.25% |
| 1996 FY | 1.7 Million USD | -5.56% |
| 1995 Q4 | 1.8 Million USD | 38.46% |
| 1995 FY | 1.8 Million USD | 12.5% |
| 1995 Q1 | 1.4 Million USD | -12.5% |
| 1995 Q2 | 1.6 Million USD | 14.29% |
| 1995 Q3 | 1.3 Million USD | -18.75% |
| 1994 Q3 | 1.7 Million USD | -26.09% |
| 1994 Q4 | 1.6 Million USD | -5.88% |
| 1994 FY | 1.6 Million USD | 0.0% |
| 1994 Q2 | 2.3 Million USD | -8.0% |
| 1994 Q1 | 2.5 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| AbCellera Biologics Inc. | 335.77 Million USD | -189.624% |
| Alkermes plc | 933.53 Million USD | -4.172% |
| Agenus Inc. | 462.29 Million USD | -110.361% |
| Alnylam Pharmaceuticals, Inc. | 4.05 Billion USD | 75.991% |
| Aptorum Group Limited | 5.25 Million USD | -18399.838% |
| Ardelyx, Inc. | 130.76 Million USD | -643.703% |
| Arrowhead Pharmaceuticals, Inc. | 478.39 Million USD | -103.284% |
| Bicycle Therapeutics plc | 224.41 Million USD | -333.349% |
| BioXcel Therapeutics, Inc. | 130.21 Million USD | -646.861% |
| ChromaDex Corporation | 26.5 Million USD | -3568.659% |
| Chimerix, Inc. | 19.74 Million USD | -4825.237% |
| Corbus Pharmaceuticals Holdings, Inc. | 35.17 Million USD | -2664.547% |
| Caribou Biosciences, Inc. | 72.56 Million USD | -1240.124% |
| CRISPR Therapeutics AG | 346.76 Million USD | -180.443% |
| Precision BioSciences, Inc. | 140.92 Million USD | -590.099% |
| Dyadic International, Inc. | 2.34 Million USD | -41447.757% |
| Eton Pharmaceuticals, Inc. | 16.26 Million USD | -5879.758% |
| Fortress Biotech, Inc. | 165.93 Million USD | -486.052% |
| Lantern Pharma Inc. | 2.73 Million USD | -35396.382% |
| HOOKIPA Pharma Inc. | 71.48 Million USD | -1260.504% |
| Inhibikase Therapeutics, Inc. | 3.52 Million USD | -27459.189% |
| Incyte Corporation | 1.59 Billion USD | 38.924% |
| IO Biotech, Inc. | 17.55 Million USD | -5439.348% |
| Jaguar Health, Inc. | 45.86 Million USD | -2020.281% |
| Novavax, Inc. | 2.57 Billion USD | 62.193% |
| Janux Therapeutics, Inc. | 36.05 Million USD | -2597.01% |
| Opthea Limited | 264.6 Million USD | -267.53% |
| Ligand Pharmaceuticals Incorporated | 130.7 Million USD | -644.021% |
| ContextLogic Inc. | 206 Million USD | -372.082% |
| MiMedx Group, Inc. | 96.33 Million USD | -909.538% |
| Pyxis Oncology, Inc. | 48.02 Million USD | -1925.089% |
| TransCode Therapeutics, Inc. | 3.52 Million USD | -27457.924% |
| NextCure, Inc. | 14.99 Million USD | -6384.55% |
| Ocuphire Pharma, Inc. | 4.04 Million USD | -23959.574% |
| Oncternal Therapeutics, Inc. | 6.67 Million USD | -14464.745% |
| Outlook Therapeutics, Inc. | 46.73 Million USD | -1980.678% |
| Vaxcyte, Inc. | 167.44 Million USD | -480.767% |
| PDS Biotechnology Corporation | 33.25 Million USD | -2823.973% |
| Madrigal Pharmaceuticals, Inc. | 235.21 Million USD | -313.448% |
| Pharming Group N.V. | 244.07 Million USD | -298.441% |
| Pieris Pharmaceuticals, Inc. | 11.92 Million USD | -8057.088% |
| Avidity Biosciences, Inc. | 127.79 Million USD | -660.999% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -14618.434% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -14618.434% |
| Sangamo Therapeutics, Inc. | 82.43 Million USD | -1079.731% |
| Sol-Gel Technologies Ltd. | 6.64 Million USD | -14539.289% |
| Acelyrin, Inc. | 86.35 Million USD | -1026.177% |
| Salarius Pharmaceuticals, Inc. | 1.29 Million USD | -74750.47% |
| SELLAS Life Sciences Group, Inc. | 14.37 Million USD | -6663.252% |
| Summit Therapeutics Inc. | 125.25 Million USD | -676.394% |
| Sensei Biotherapeutics, Inc. | 9.47 Million USD | -10159.394% |
| Senti Biosciences, Inc. | 52.57 Million USD | -1749.856% |
| Stoke Therapeutics, Inc. | 68.77 Million USD | -1313.973% |
| Syros Pharmaceuticals, Inc. | 151.51 Million USD | -541.855% |
| Alaunos Therapeutics, Inc. | 1.95 Million USD | -49618.2% |
| Telomir Pharmaceuticals, Inc. Common Stock | 1.33 Million USD | -72714.781% |
| Entrada Therapeutics, Inc. | 226.83 Million USD | -328.726% |
| VistaGen Therapeutics, Inc. | 9.36 Million USD | -10282.065% |
| Wave Life Sciences Ltd. | 227.44 Million USD | -327.571% |
| Sorrento Therapeutics, Inc. | 494.5 Million USD | -96.657% |
| TRACON Pharmaceuticals, Inc. | 10.91 Million USD | -8810.464% |
| Barinthus Biotherapeutics plc | 27.51 Million USD | -3434.906% |
| Psyence Biomedical Ltd. | 12.1 Million USD | -7933.971% |
| Phathom Pharmaceuticals, Inc. | 486.6 Million USD | -99.853% |
| Immix Biopharma, Inc. | 3.72 Million USD | -26029.627% |
| Keros Therapeutics, Inc. | 37.81 Million USD | -2471.903% |
| MEI Pharma, Inc. | 8.35 Million USD | -11539.593% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | -3251.673% |
| Xeris Biopharma Holdings, Inc. | 347.58 Million USD | -179.788% |
| Rigel Pharmaceuticals, Inc. | 145.86 Million USD | -566.686% |
| Fortress Biotech, Inc. | 165.93 Million USD | -486.052% |
| Precigen, Inc. | 41.64 Million USD | -2235.242% |
| Clearside Biomedical, Inc. | 49.93 Million USD | -1847.703% |
| AlloVir, Inc. | 45.01 Million USD | -2060.364% |
| C4 Therapeutics, Inc. | 130.33 Million USD | -646.133% |
| Fate Therapeutics, Inc. | 137.8 Million USD | -605.724% |
| ImmuCell Corporation | 18.81 Million USD | -5068.678% |
| IDEAYA Biosciences, Inc. | 28.22 Million USD | -3345.362% |
| Onconetix, Inc. | 23.18 Million USD | -4095.215% |
| PureTech Health plc | 125.58 Million USD | -674.379% |
| VYNE Therapeutics Inc. | 8.95 Million USD | -10765.788% |
| Elevation Oncology, Inc. | 34.28 Million USD | -2736.731% |
| Kintara Therapeutics, Inc. | 2.44 Million USD | -39674.56% |
| Seer, Inc. | 39.36 Million USD | -2370.438% |
| Verrica Pharmaceuticals Inc. | 61.83 Million USD | -1472.74% |
| Innoviva, Inc. | 568.55 Million USD | -71.046% |
| Aadi Bioscience, Inc. | 27.22 Million USD | -3471.647% |
| ESSA Pharma Inc. | 3.49 Million USD | -27724.556% |
| GlycoMimetics, Inc. | 6.9 Million USD | -13989.794% |
| GT Biopharma, Inc. | 6.63 Million USD | -14561.36% |
| Inhibrx Biosciences, Inc. | 264.39 Million USD | -267.823% |
| Akebia Therapeutics, Inc. | 272.28 Million USD | -257.156% |
| Catalyst Pharmaceuticals, Inc. | 84.02 Million USD | -1057.366% |
| Longboard Pharmaceuticals, Inc. | 9.77 Million USD | -9849.744% |
| Orchestra BioMed Holdings, Inc. | 27.16 Million USD | -3479.403% |
| Alzamend Neuro, Inc. | 3.22 Million USD | -30047.441% |
| Rocket Pharmaceuticals, Inc. | 73.76 Million USD | -1218.324% |
| Aptose Biosciences Inc. | 15.8 Million USD | -6051.6% |
| ZyVersa Therapeutics, Inc. | 11.03 Million USD | -8709.019% |
| Soligenix, Inc. | 7.27 Million USD | -13267.709% |
| Century Therapeutics, Inc. | 175.94 Million USD | -452.735% |
| Kura Oncology, Inc. | 51.66 Million USD | -1782.405% |
| TScan Therapeutics, Inc. | 121.28 Million USD | -701.84% |
| Intensity Therapeutics, Inc. | 4.13 Million USD | -23429.833% |
| Ocean Biomedical, Inc. | 6.61 Million USD | -14603.8% |
| CytomX Therapeutics, Inc. | 252.59 Million USD | -284.994% |
| Autolus Therapeutics plc | 263.9 Million USD | -268.496% |
| Mineralys Therapeutics, Inc. | 10.48 Million USD | -9177.695% |
| EyePoint Pharmaceuticals, Inc. | 88.86 Million USD | -994.392% |
| Eterna Therapeutics Inc. | 46.89 Million USD | -1973.579% |
| Adaptive Biotechnologies Corporation | 352.85 Million USD | -175.605% |
| GRI Bio, Inc. | 2.69 Million USD | -35958.139% |
| Xenetic Biosciences, Inc. | 809.58 Thousand USD | -120021.791% |
| Tenaya Therapeutics, Inc. | 31.09 Million USD | -3027.876% |
| IGM Biosciences, Inc. | 220.17 Million USD | -341.685% |
| INmune Bio, Inc. | 18.86 Million USD | -5055.805% |
| Heron Therapeutics, Inc. | 256.47 Million USD | -279.169% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -3550.232% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -35674.2% |
| Entero Therapeutics, Inc. | 3.28 Million USD | -29546.62% |
| Milestone Pharmaceuticals Inc. | 58.45 Million USD | -1563.652% |
| X4 Pharmaceuticals, Inc. | 96.15 Million USD | -911.333% |
| Atara Biotherapeutics, Inc. | 264.73 Million USD | -267.344% |
| Coherus BioSciences, Inc. | 823.02 Million USD | -18.16% |
| Verastem, Inc. | 71.18 Million USD | -1266.142% |
| Abeona Therapeutics Inc. | 49.17 Million USD | -1877.566% |
| Pliant Therapeutics, Inc. | 38.57 Million USD | -2420.836% |
| Tonix Pharmaceuticals Holding Corp. | 48.93 Million USD | -1887.427% |
| Histogen Inc. | 5.69 Million USD | -16970.177% |
| Aprea Therapeutics, Inc. | 4.38 Million USD | -22074.546% |
| Surrozen, Inc. | 8.14 Million USD | -11839.693% |
| Organovo Holdings, Inc. | 2.74 Million USD | -35288.937% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -309749.677% |
| Ovid Therapeutics Inc. | 56.22 Million USD | -1629.486% |
| Panbela Therapeutics, Inc. | 16.51 Million USD | -5789.583% |
| CASI Pharmaceuticals, Inc. | 51.1 Million USD | -1802.996% |
| Cadrenal Therapeutics, Inc. Common Stock | 826.87 Thousand USD | -117510.038% |
| Centessa Pharmaceuticals plc | 126.72 Million USD | -667.4% |
| Hepion Pharmaceuticals, Inc. | 10.81 Million USD | -8893.202% |
| Arcturus Therapeutics Holdings Inc. | 150.88 Million USD | -544.506% |
| BioRestorative Therapies, Inc. | 2.6 Million USD | -37198.018% |
| Apollomics, Inc. | 14.15 Million USD | -6771.25% |
| Amarin Corporation plc | 279.58 Million USD | -247.83% |
| Mesoblast Limited | 188.79 Million USD | -415.094% |
| Turnstone Biologics Corp. | 14.14 Million USD | -6773.678% |
| Kymera Therapeutics, Inc. | 180.78 Million USD | -437.916% |
| Synaptogenix, Inc. | 5.52 Million USD | -17487.367% |
| Tiziana Life Sciences Ltd | 6.64 Million USD | -14528.279% |
| Aurinia Pharmaceuticals Inc. | 170.1 Million USD | -471.689% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -11264.568% |
| Monopar Therapeutics Inc. | 1.75 Million USD | -55236.968% |
| Exelixis, Inc. | 678.44 Million USD | -43.341% |
| Better Therapeutics, Inc. | 23.84 Million USD | -3978.886% |
| Nurix Therapeutics, Inc. | 164.04 Million USD | -492.814% |
| Apellis Pharmaceuticals, Inc. | 594.2 Million USD | -63.661% |
| NLS Pharmaceutics AG | 10.68 Million USD | -9005.519% |
| Dermata Therapeutics, Inc. | 1.62 Million USD | -59796.429% |
| Aridis Pharmaceuticals, Inc. | 38.92 Million USD | -2398.235% |
| Gritstone bio, Inc. | 125.91 Million USD | -672.312% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -6526.383% |
| TNF Pharmaceuticals, Inc. | 5.08 Million USD | -19011.01% |
| Avid Bioservices, Inc. | 275.66 Million USD | -252.775% |
| Insmed Incorporated | 1.66 Billion USD | 41.478% |
| Virpax Pharmaceuticals, Inc. | 7.69 Million USD | -12539.524% |
| MediWound Ltd. | 27.18 Million USD | -3477.033% |
| OmniAb, Inc. | 87.4 Million USD | -1012.686% |
| Alector, Inc. | 487.66 Million USD | -99.416% |
| Seres Therapeutics, Inc. | 403.45 Million USD | -141.039% |
| Checkpoint Therapeutics, Inc. | 18.42 Million USD | -5178.09% |
| Viracta Therapeutics, Inc. | 38.37 Million USD | -2434.303% |
| Zai Lab Limited | 240.17 Million USD | -304.905% |
| Revance Therapeutics, Inc. | 630.05 Million USD | -54.349% |
| Aura Biosciences, Inc. | 29.22 Million USD | -3227.362% |
| Lyell Immunopharma, Inc. | 95.07 Million USD | -922.843% |
| Immunic, Inc. | 25.36 Million USD | -3733.523% |
| Tarsus Pharmaceuticals, Inc. | 69.23 Million USD | -1304.599% |
| Veracyte, Inc. | 93.71 Million USD | -937.664% |
| InMed Pharmaceuticals Inc. | 2.61 Million USD | -37065.057% |
| FibroGen, Inc. | 585.72 Million USD | -66.031% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -5494.477% |
| Adial Pharmaceuticals, Inc. | 653.07 Thousand USD | -148808.856% |
| Sonnet BioTherapeutics Holdings, Inc. | 5.65 Million USD | -17095.566% |
| Jazz Pharmaceuticals plc | 7.65 Billion USD | 87.298% |
| Cyclacel Pharmaceuticals, Inc. | 8.19 Million USD | -11762.503% |
| Amylyx Pharmaceuticals, Inc. | 84.02 Million USD | -1057.421% |
| TG Therapeutics, Inc. | 169.08 Million USD | -475.147% |
| Galecto, Inc. | 5.89 Million USD | -16394.03% |
| Calithera Biosciences, Inc. | 8.28 Million USD | -11639.353% |
| Fortrea Holdings Inc. | 2.61 Billion USD | 62.859% |
| KalVista Pharmaceuticals, Inc. | 28.82 Million USD | -3274.117% |
| Aptevo Therapeutics Inc. | 12.62 Million USD | -7605.317% |
| XBiotech Inc. | 8.39 Million USD | -11481.374% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -6526.383% |
| Lyra Therapeutics, Inc. | 53.18 Million USD | -1728.672% |
| Foghorn Therapeutics Inc. | 363.1 Million USD | -167.825% |
| Y-mAbs Therapeutics, Inc. | 26.88 Million USD | -3517.349% |
| Theravance Biopharma, Inc. | 169 Million USD | -475.423% |
| Ultragenyx Pharmaceutical Inc. | 1.21 Billion USD | 19.999% |
| Metagenomi, Inc. Common Stock | 500.42 Million USD | -94.332% |
| Vaxxinity, Inc. | 30.94 Million USD | -3042.735% |
| Gain Therapeutics, Inc. | 6.03 Million USD | -16024.536% |
| Cartesian Therapeutics, Inc. | 745.23 Million USD | -30.494% |
| NexImmune, Inc. | 5.08 Million USD | -19027.53% |
| Creative Medical Technology Holdings, Inc. | 371.39 Thousand USD | -261748.064% |
| Marker Therapeutics, Inc. | 3.07 Million USD | -31527.189% |
| Regeneron Pharmaceuticals, Inc. | 7.1 Billion USD | 86.317% |
| Chemomab Therapeutics Ltd. | 5.15 Million USD | -18768.497% |
| Scopus BioPharma Inc. | 7.45 Million USD | -12945.766% |
| RAPT Therapeutics, Inc. | 26.29 Million USD | -3598.517% |
| Ainos, Inc. | 7.39 Million USD | -13051.997% |
| Pluri Inc. | 34.11 Million USD | -2750.868% |
| Prothena Corporation plc | 135.01 Million USD | -620.271% |
| Adaptimmune Therapeutics plc | 243.1 Million USD | -300.031% |
| Celularity Inc. | 102.92 Million USD | -844.814% |
| Rallybio Corporation | 9.43 Million USD | -10206.147% |
| Cue Biopharma, Inc. | 24.44 Million USD | -3878.27% |
| MeiraGTx Holdings plc | 319.99 Million USD | -203.911% |
| Omeros Corporation | 403.25 Million USD | -141.161% |
| Humacyte, Inc. | 114.67 Million USD | -748.024% |
| Immunocore Holdings plc | 228.15 Million USD | -326.234% |
| Cocrystal Pharma, Inc. | 4.87 Million USD | -19848.472% |
| Cidara Therapeutics, Inc. | 76.74 Million USD | -1167.25% |
| Blueprint Medicines Corporation | 918.64 Million USD | -5.862% |
| CalciMedica, Inc. | 4.02 Million USD | -24043.198% |
| Cabaletta Bio, Inc. | 17.45 Million USD | -5472.358% |
| Marinus Pharmaceuticals, Inc. | 154.14 Million USD | -530.9% |
| Scholar Rock Holding Corporation | 85.81 Million USD | -1033.211% |
| Sana Biotechnology, Inc. | 277.79 Million USD | -250.076% |
| Pulmatrix, Inc. | 15.96 Million USD | -5992.138% |
| Elicio Therapeutics, Inc. | 15.77 Million USD | -6065.523% |
| Vigil Neuroscience, Inc. | 24.6 Million USD | -3852.239% |
| Intellia Therapeutics, Inc. | 250.8 Million USD | -287.742% |
| Adlai Nortye Ltd. American Depositary Shares | 50.78 Million USD | -1814.874% |
| Cytokinetics, Incorporated | 1.21 Billion USD | 19.672% |
| Eloxx Pharmaceuticals, Inc. | 31.78 Million USD | -2959.774% |
| Nutriband Inc. | 1.07 Million USD | -90035.404% |
| Protara Therapeutics, Inc. | 10.63 Million USD | -9045.942% |
| Vor Biopharma Inc. | 59.1 Million USD | -1545.384% |
| Roivant Sciences Ltd. | 773.95 Million USD | -25.652% |
| Evogene Ltd. | 17.99 Million USD | -5305.714% |
| ProKidney Corp. | 29.21 Million USD | -3228.614% |
| Applied Therapeutics, Inc. | 71.97 Million USD | -1251.072% |
| Hoth Therapeutics, Inc. | 704.98 Thousand USD | -137844.887% |
| BridgeBio Pharma, Inc. | 1.88 Billion USD | 48.516% |
| CorMedix Inc. | 11.91 Million USD | -8060.149% |
| BioLineRx Ltd. | 50.7 Million USD | -1818.047% |
| Tango Therapeutics, Inc. | 149.45 Million USD | -550.672% |
| Galectin Therapeutics Inc. | 88.44 Million USD | -999.59% |
| Atai Life Sciences N.V. | 49.16 Million USD | -1878.129% |
| Renovaro Biosciences Inc. | 31.15 Million USD | -3021.721% |
| Aerovate Therapeutics, Inc. | 17.96 Million USD | -5314.141% |
| Zentalis Pharmaceuticals, Inc. | 124.63 Million USD | -680.263% |
| Sagimet Biosciences Inc. | 5.65 Million USD | -17100.0% |
| MediciNova, Inc. | 3.89 Million USD | -24889.715% |
| Praxis Precision Medicines, Inc. | 18.27 Million USD | -5220.247% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -64549.747% |
| GeoVax Labs, Inc. | 3.51 Million USD | -27528.434% |
| Axsome Therapeutics, Inc. | 397.25 Million USD | -144.799% |
| Biomea Fusion, Inc. | 30.69 Million USD | -3068.746% |
| PTC Therapeutics, Inc. | 2.72 Billion USD | 64.27% |
| Mereo BioPharma Group plc | 15.96 Million USD | -5992.52% |
| Cullinan Oncology, Inc. | 31.2 Million USD | -3016.849% |
| Syndax Pharmaceuticals, Inc. | 58.68 Million USD | -1557.16% |
| Absci Corporation | 58.3 Million USD | -1567.961% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -5005.46% |
| 4D Molecular Therapeutics, Inc. | 32.06 Million USD | -2933.148% |
| Dyne Therapeutics, Inc. | 73.79 Million USD | -1217.913% |
| Kiniksa Pharmaceuticals, Ltd. | 87.48 Million USD | -1011.631% |
| Ventyx Biosciences, Inc. | 33.77 Million USD | -2779.739% |
| Allakos Inc. | 74.79 Million USD | -1200.239% |
| Imunon, Inc. | 8.53 Million USD | -11300.227% |
| Fulcrum Therapeutics, Inc. | 22.5 Million USD | -4221.977% |
| Corcept Therapeutics Incorporated | 114.81 Million USD | -747.026% |
| BioAtla, Inc. | 48.98 Million USD | -1885.237% |
| NLS Pharmaceutics AG | 10.68 Million USD | -9005.519% |
| Bio-Path Holdings, Inc. | 2.77 Million USD | -34894.171% |
| Allogene Therapeutics, Inc. | 130.6 Million USD | -644.608% |
| Larimar Therapeutics, Inc. | 14.21 Million USD | -6741.28% |
| XOMA Corporation | 145.58 Million USD | -568.009% |
| Kezar Life Sciences, Inc. | 33.66 Million USD | -2788.721% |
| Cara Therapeutics, Inc. | 68.75 Million USD | -1314.343% |
| aTyr Pharma, Inc. | 31.59 Million USD | -2977.786% |
| Aligos Therapeutics, Inc. | 61.82 Million USD | -1473.02% |
| Akero Therapeutics, Inc. | 44.96 Million USD | -2062.767% |
| Viridian Therapeutics, Inc. | 48.4 Million USD | -1909.19% |
| Eliem Therapeutics, Inc. | 2.87 Million USD | -33784.599% |
| EyeGate Pharmaceuticals, Inc. | 8.15 Million USD | -11820.641% |
| Akari Therapeutics, Plc | 4.58 Million USD | -21114.834% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -5384.018% |
| Halozyme Therapeutics, Inc. | 1.64 Billion USD | 41.042% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -240669.68% |
| UroGen Pharma Ltd. | 243.52 Million USD | -299.341% |
| Sutro Biopharma, Inc. | 321.08 Million USD | -202.874% |
| ZIVO Bioscience, Inc. | 2.76 Million USD | -35115.194% |
| Orgenesis Inc. | 35.53 Million USD | -2636.705% |
| Entera Bio Ltd. | 1.37 Million USD | -70421.247% |
| GH Research PLC | 6.7 Million USD | -14412.58% |
| Lisata Therapeutics, Inc. | 6.8 Million USD | -14201.294% |
| Reneo Pharmaceuticals, Inc. | 18.82 Million USD | -5065.665% |
| Xencor, Inc. | 283.55 Million USD | -242.958% |
| 60 Degrees Pharmaceuticals, Inc. | 2.98 Million USD | -32471.797% |
| Replimune Group, Inc. | 113.21 Million USD | -758.982% |
| Coeptis Therapeutics Holdings, Inc. | 3.75 Million USD | -25783.834% |
| Vanda Pharmaceuticals Inc. | 103.53 Million USD | -839.33% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -240669.68% |
| Portage Biotech Inc. | 4.45 Million USD | -21753.663% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -64549.747% |
| Olema Pharmaceuticals, Inc. | 23.05 Million USD | -4119.037% |
| OncoCyte Corporation | 49.29 Million USD | -1872.672% |
| Qualigen Therapeutics, Inc. | 4.13 Million USD | -23408.19% |
| Processa Pharmaceuticals, Inc. | 797.48 Thousand USD | -121844.516% |
| Purple Biotech Ltd. | 10 Million USD | -9620.02% |
| CollPlant Biotechnologies Ltd. | 5.78 Million USD | -16707.605% |
| scPharmaceuticals Inc. | 57.26 Million USD | -1598.343% |
| ProMIS Neurosciences, Inc. | 12.38 Million USD | -7750.229% |
| HilleVax, Inc. | 78.9 Million USD | -1132.417% |
| NeuroSense Therapeutics Ltd. | 5.05 Million USD | -19157.188% |
| Tharimmune, Inc. | 1.81 Million USD | -53479.248% |
| Genprex, Inc. | 3.25 Million USD | -29784.015% |
| Neumora Therapeutics, Inc. Common Stock | 27.11 Million USD | -3486.002% |
| Atossa Therapeutics, Inc. | 5.23 Million USD | -18473.109% |
| XTL Biopharmaceuticals Ltd. | 206 Thousand USD | -471981.553% |
| Virios Therapeutics, Inc. | 358.54 Thousand USD | -271129.515% |
| OKYO Pharma Limited | 7.42 Million USD | -13004.813% |
| Savara Inc. | 37.19 Million USD | -2514.777% |
| Curis, Inc. | 57.61 Million USD | -1587.996% |
| Daré Bioscience, Inc. | 26.32 Million USD | -3593.48% |
| Carmell Therapeutics Corporation | 39.19 Million USD | -2380.85% |
| Titan Pharmaceuticals, Inc. | 1.44 Million USD | -67246.814% |
| Achieve Life Sciences, Inc. | 20.81 Million USD | -4571.156% |
| BeiGene, Ltd. | 2.23 Billion USD | 56.464% |
| Kiromic BioPharma, Inc. | 21.28 Million USD | -4467.859% |
| Revolution Medicines, Inc. Warrant | 262.39 Million USD | -270.617% |
| Protagonist Therapeutics, Inc. | 21.27 Million USD | -4471.251% |
| Erasca, Inc. | 78.61 Million USD | -1137.089% |
| bluebird bio, Inc. | 424.62 Million USD | -129.023% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -148314.351% |
| BioMarin Pharmaceutical Inc. | 1.89 Billion USD | 48.547% |
| DBV Technologies S.A. | 42.8 Million USD | -2172.168% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -148314.351% |
| Moderna, Inc. | 4.57 Billion USD | 78.729% |
| Vincerx Pharma, Inc. | 6.99 Million USD | -13802.616% |
| Fresh Tracks Therapeutics, Inc. | 1.65 Million USD | -58625.121% |
| Molecular Templates, Inc. | 31.17 Million USD | -3019.849% |
| Acrivon Therapeutics, Inc. Common Stock | 17.07 Million USD | -5597.059% |
| Travere Therapeutics, Inc. | 588.1 Million USD | -65.36% |
| Monte Rosa Therapeutics, Inc. | 124.5 Million USD | -681.083% |
| Spruce Biosciences, Inc. | 27.43 Million USD | -3444.44% |
| Celldex Therapeutics, Inc. | 36.45 Million USD | -2567.566% |
| Cogent Biosciences, Inc. | 55.63 Million USD | -1647.979% |
| MacroGenics, Inc. | 154.2 Million USD | -530.638% |
| RenovoRx, Inc. | 4.46 Million USD | -21675.369% |
| Adicet Bio, Inc. | 37.12 Million USD | -2519.849% |
| Prime Medicine, Inc. | 60.78 Million USD | -1500.013% |
| Aditxt, Inc. | 28.53 Million USD | -3308.464% |
| Adagene Inc. | 45.16 Million USD | -2052.982% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -538075.218% |
| Quantum-Si incorporated | 26.63 Million USD | -3551.714% |
| Maravai LifeSciences Holdings, Inc. | 697.56 Million USD | -39.412% |
| Acurx Pharmaceuticals, Inc. | 3.04 Million USD | -31864.102% |
| Voyager Therapeutics, Inc. | 114.96 Million USD | -745.929% |
| SciSparc Ltd. | 1.59 Million USD | -60871.034% |
| Vericel Corporation | 127.7 Million USD | -661.511% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -17375.409% |
| Minerva Neurosciences, Inc. | 85.35 Million USD | -1039.304% |
| Generation Bio Co. | 171.63 Million USD | -466.619% |
| Astria Therapeutics, Inc. | 11.55 Million USD | -8319.81% |
| Black Diamond Therapeutics, Inc. | 41.83 Million USD | -2224.802% |
| Arcutis Biotherapeutics, Inc. | 252.69 Million USD | -284.842% |
| Invivyd, Inc. | 51.71 Million USD | -1780.548% |
| Relay Therapeutics, Inc. | 91.97 Million USD | -957.317% |
| Quoin Pharmaceuticals, Ltd. | 6.5 Million USD | -14849.277% |
| Spero Therapeutics, Inc. | 75.49 Million USD | -1188.132% |
| Artelo Biosciences, Inc. | 1.02 Million USD | -95148.58% |
| 2seventy bio, Inc. | 310.12 Million USD | -213.578% |
| ADMA Biologics, Inc. | 193.97 Million USD | -401.344% |
| Clene Inc. | 38.95 Million USD | -2396.696% |
| Capricor Therapeutics, Inc. | 36.13 Million USD | -2591.423% |
| Boundless Bio, Inc. Common Stock | 256.97 Million USD | -278.435% |
| GeoVax Labs, Inc. | 3.51 Million USD | -27528.434% |
| Recursion Pharmaceuticals, Inc. | 190.26 Million USD | -411.128% |
| Citius Pharmaceuticals, Inc. | 12.17 Million USD | -7884.524% |
| Contineum Therapeutics, Inc. Class A Common Stock | 198.32 Million USD | -390.358% |
| Relmada Therapeutics, Inc. | 12.19 Million USD | -7874.612% |
| Finch Therapeutics Group, Inc. | 48.11 Million USD | -1921.342% |
| ALX Oncology Holdings Inc. | 52.84 Million USD | -1740.404% |
| Vir Biotechnology, Inc. | 369.85 Million USD | -162.938% |
| Evaxion Biotech A/S | 17.61 Million USD | -5420.018% |
| Ocular Therapeutix, Inc. | 160.92 Million USD | -504.296% |
| Verve Therapeutics, Inc. | 153.18 Million USD | -534.841% |
| Trevena, Inc. | 48.26 Million USD | -1915.018% |
| Surrozen, Inc. | 8.14 Million USD | -11839.693% |
| Tyra Biosciences, Inc. | 21.59 Million USD | -4403.302% |
| Cingulate Inc. | 10.36 Million USD | -9286.166% |
| Galmed Pharmaceuticals Ltd. | 2.75 Million USD | -35263.2% |
| Unity Biotechnology, Inc. | 37.29 Million USD | -2507.766% |
| Tenax Therapeutics, Inc. | 3.58 Million USD | -27015.086% |
| Terns Pharmaceuticals, Inc. | 13.15 Million USD | -7295.346% |
| ACADIA Pharmaceuticals Inc. | 317.2 Million USD | -206.584% |
| Connect Biopharma Holdings Limited | 24.84 Million USD | -3813.59% |
| Clearmind Medicine Inc. | 3.61 Million USD | -26838.666% |
| Kronos Bio, Inc. | 54.2 Million USD | -1694.225% |
| Bolt Biotherapeutics, Inc. | 47.04 Million USD | -1967.232% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -4172.845% |
| Viking Therapeutics, Inc. | 20.07 Million USD | -4745.239% |
| Statera Biopharma, Inc. | 22.67 Million USD | -4188.537% |
| ImmunityBio, Inc. | 1.09 Billion USD | 10.813% |
| Korro Bio, Inc. | 51.75 Million USD | -1779.131% |
| Kineta, Inc. | 7.22 Million USD | -13365.633% |
| BioVie Inc. | 9.7 Million USD | -9923.448% |
| Codexis, Inc. | 49.94 Million USD | -1847.079% |
| Celularity Inc. | 102.92 Million USD | -844.814% |
| Crinetics Pharmaceuticals, Inc. | 96.24 Million USD | -910.409% |
| Celcuity Inc. | 51.45 Million USD | -1790.159% |
| Virax Biolabs Group Limited | 345.19 Thousand USD | -281622.162% |
| Cibus, Inc. | 206.11 Million USD | -371.814% |
| Eledon Pharmaceuticals, Inc. | 42.47 Million USD | -2189.554% |
| eFFECTOR Therapeutics, Inc. | 26.33 Million USD | -3592.198% |
| IN8bio, Inc. | 8.77 Million USD | -10986.275% |
| Kodiak Sciences Inc. | 213.59 Million USD | -355.304% |
| Annexon, Inc. | 47.11 Million USD | -1963.942% |
| Adverum Biotechnologies, Inc. | 89.54 Million USD | -986.081% |
| Assembly Biosciences, Inc. | 96.37 Million USD | -909.098% |
| Avalo Therapeutics, Inc. | 13.68 Million USD | -7004.157% |
| Ionis Pharmaceuticals, Inc. | 2.6 Billion USD | 62.645% |
| Eyenovia, Inc. | 19.78 Million USD | -4816.452% |
| Puma Biotechnology, Inc. | 177.08 Million USD | -449.161% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -12560.956% |
| Xilio Therapeutics, Inc. | 24.09 Million USD | -3935.387% |
| Arcellx, Inc. | 339.75 Million USD | -186.235% |
| Cardiff Oncology, Inc. | 11.89 Million USD | -8073.542% |
| Enanta Pharmaceuticals, Inc. | 245.54 Million USD | -296.061% |
| Regulus Therapeutics Inc. | 9.56 Million USD | -10069.277% |
| Moolec Science SA | 13.94 Million USD | -6873.562% |
| Acumen Pharmaceuticals, Inc. | 43.15 Million USD | -2153.634% |
| Geron Corporation | 146.12 Million USD | -565.509% |
| LAVA Therapeutics N.V. | 50.53 Million USD | -1824.499% |
| Royalty Pharma plc | 6.29 Billion USD | 84.558% |
| Atea Pharmaceuticals, Inc. | 39.77 Million USD | -2344.912% |
| Greenwich LifeSciences, Inc. | 294.4 Thousand USD | -330222.072% |
| TFF Pharmaceuticals, Inc. | 2.46 Million USD | -39427.501% |
| Mersana Therapeutics, Inc. | 189.15 Million USD | -414.12% |
| Humacyte, Inc. | 114.67 Million USD | -748.024% |
| Structure Therapeutics Inc. | 29.05 Million USD | -3247.519% |
| 89bio, Inc. | 59.96 Million USD | -1521.813% |
| PMV Pharmaceuticals, Inc. | 26.46 Million USD | -3574.897% |
| Avenue Therapeutics, Inc. | 1.19 Million USD | -81211.706% |
| Genelux Corporation | 8.42 Million USD | -11449.739% |
| Trevi Therapeutics, Inc. | 6.85 Million USD | -14084.481% |
| Lexicon Pharmaceuticals, Inc. | 136.31 Million USD | -613.391% |
| Notable Labs, Ltd. | 4.42 Million USD | -21867.201% |
| Liquidia Corporation | 73.13 Million USD | -1229.662% |
| Mustang Bio, Inc. | 17.61 Million USD | -5419.541% |
| Immunovant, Inc. | 48.95 Million USD | -1886.494% |
| Quantum-Si incorporated | 26.63 Million USD | -3551.714% |
| Arbutus Biopharma Corporation | 38.38 Million USD | -2433.642% |
| DiaMedica Therapeutics Inc. | 3.1 Million USD | -31240.251% |
| Vera Therapeutics, Inc. | 73.86 Million USD | -1216.646% |
| Acasti Pharma Inc. | 11.55 Million USD | -8314.71% |
| MiNK Therapeutics, Inc. | 22.6 Million USD | -4201.573% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -35674.2% |
| Xenon Pharmaceuticals Inc. | 36.87 Million USD | -2537.113% |
| Elevai Labs, Inc. Common Stock | 1.36 Million USD | -71257.355% |
| NeuroBo Pharmaceuticals, Inc. | 6.09 Million USD | -15852.887% |
| Tempest Therapeutics, Inc. | 24.83 Million USD | -3815.796% |
| Soleno Therapeutics, Inc. | 23.18 Million USD | -4094.651% |
| PepGen Inc. | 34.63 Million USD | -2708.143% |
| Moleculin Biotech, Inc. | 12.14 Million USD | -7907.971% |
| United Therapeutics Corporation | 1.18 Billion USD | 17.739% |
| Nuvectis Pharma, Inc. | 6.98 Million USD | -13824.513% |
| Solid Biosciences Inc. | 38.45 Million USD | -2428.701% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -11264.568% |
| Immuneering Corporation | 12 Million USD | -7998.428% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -309749.677% |
| Silo Pharma, Inc. | 1.56 Million USD | -61870.725% |
| Belite Bio, Inc | 4.21 Million USD | -22993.992% |
| XOMA Corporation | 145.58 Million USD | -568.009% |
| ARS Pharmaceuticals, Inc. | 2.42 Million USD | -39953.048% |
| Bionomics Limited | 10.15 Million USD | -9472.937% |
| Apogee Therapeutics, Inc. | 21.49 Million USD | -4425.094% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -4144.263% |
| uniQure N.V. | 624.01 Million USD | -55.843% |
| Cassava Sciences, Inc. | 14.19 Million USD | -6750.919% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -538075.218% |
| Poseida Therapeutics, Inc. | 170.18 Million USD | -471.433% |
| Forte Biosciences, Inc. | 3.66 Million USD | -26427.223% |
| Anebulo Pharmaceuticals, Inc. | 260.58 Thousand USD | -373097.024% |
| Enlivex Therapeutics Ltd. | 6.74 Million USD | -14313.636% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -12560.956% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -5494.477% |
| FibroBiologics, Inc. Common Stock | 10.56 Million USD | -9102.195% |
| Altimmune, Inc. | 16.54 Million USD | -5779.258% |
| Amicus Therapeutics, Inc. | 617.7 Million USD | -57.435% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -4144.263% |
| Compugen Ltd. | 55.77 Million USD | -1643.591% |
| Peak Bio, Inc. | 20.75 Million USD | -4585.929% |
| Zevra Therapeutics, Inc. | 110.46 Million USD | -780.374% |
| Benitec Biopharma Inc. | 4.96 Million USD | -19498.71% |
| Spyre Therapeutics, Inc. | 157.84 Million USD | -516.111% |
| NKGen Biotech, Inc. Common Stock | 75.17 Million USD | -1193.649% |
| Zura Bio Limited | 21.29 Million USD | -4467.387% |
| PolyPid Ltd. | 17.46 Million USD | -5467.254% |
| Aileron Therapeutics, Inc. | 112.39 Million USD | -765.211% |
| NKGen Biotech, Inc. Warrants | 75.17 Million USD | -1193.649% |
| Instil Bio, Inc. | 99.8 Million USD | -874.427% |
| argenx SE | 444.95 Million USD | -118.561% |
| Immunome, Inc. | 28.65 Million USD | -3293.426% |
| Compass Therapeutics, Inc. | 8.33 Million USD | -11564.724% |
| Verona Pharma plc | 58.84 Million USD | -1552.739% |
| enGene Holdings Inc. Warrants | 14.47 Million USD | -6619.326% |
| Shattuck Labs, Inc. | 14.85 Million USD | -6444.774% |
| CervoMed Inc. | 2.59 Million USD | -37364.668% |
| LENZ Therapeutics, Inc. | 4.87 Million USD | -19852.565% |
| Plus Therapeutics, Inc. | 12.73 Million USD | -7535.741% |
| Dianthus Therapeutics, Inc. | 10.53 Million USD | -9131.02% |
| Moolec Science SA | 13.94 Million USD | -6873.562% |
| Enveric Biosciences, Inc. | 2.34 Million USD | -41397.177% |
| Inovio Pharmaceuticals, Inc. | 55.59 Million USD | -1649.227% |
| AnaptysBio, Inc. | 364.28 Million USD | -166.957% |
| Design Therapeutics, Inc. | 11.95 Million USD | -8033.891% |
| Leap Therapeutics, Inc. | 12.68 Million USD | -7567.045% |
| NeurAxis, Inc. | 1.91 Million USD | -50742.692% |
| Seelos Therapeutics, Inc. | 38.92 Million USD | -2398.171% |
| Lumos Pharma, Inc. | 13.33 Million USD | -7193.842% |
| Achilles Therapeutics plc | 19.08 Million USD | -4995.028% |
| enGene Holdings Inc. Common Stock | 14.47 Million USD | -6619.326% |
| 180 Life Sciences Corp. | 5.38 Million USD | -17951.796% |
| Opiant Pharmaceuticals, Inc. | 23.58 Million USD | -4022.81% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -4172.845% |
| Nutriband Inc. | 1.07 Million USD | -90035.404% |
| ORIC Pharmaceuticals, Inc. | 30.59 Million USD | -3078.273% |
| CG Oncology, Inc. Common stock | 14.51 Million USD | -6601.73% |
| Fractyl Health, Inc. Common Stock | 401.27 Million USD | -142.35% |
| Rani Therapeutics Holdings, Inc. | 32.47 Million USD | -2894.759% |
| MoonLake Immunotherapeutics | 13.04 Million USD | -7352.532% |
| Palisade Bio, Inc. | 2.73 Million USD | -35405.221% |
| Tourmaline Bio, Inc. | 5.25 Million USD | -18413.002% |
| Beam Therapeutics Inc. | 478.38 Million USD | -103.286% |
| Neurogene Inc. | 36.54 Million USD | -2560.779% |
| Mirum Pharmaceuticals, Inc. | 397.95 Million USD | -144.374% |
| AEON Biopharma, Inc. | 159.88 Million USD | -508.227% |
| CARGO Therapeutics, Inc. Common Stock | 47.65 Million USD | -1940.898% |
| Sesen Bio, Inc. | 30.98 Million USD | -3038.678% |
| Enliven Therapeutics, Inc. | 25.96 Million USD | -3645.957% |
| Kiora Pharmaceuticals, Inc. | 7.6 Million USD | -12692.165% |
| Iovance Biotherapeutics, Inc. | 195.73 Million USD | -396.831% |
| Taysha Gene Therapies, Inc. | 192.05 Million USD | -406.354% |
| Athira Pharma, Inc. | 30.05 Million USD | -3135.479% |
| Vaccinex, Inc. | 5.94 Million USD | -16266.341% |
| HCW Biologics Inc. | 15.05 Million USD | -6360.88% |
| XOMA Corporation | 145.58 Million USD | -568.009% |
| Nektar Therapeutics | 267.04 Million USD | -264.165% |
| Arvinas, Inc. | 644.6 Million USD | -50.867% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -5384.018% |
| Merus N.V. | 102.15 Million USD | -852.01% |
| Omega Therapeutics, Inc. | 146.35 Million USD | -564.495% |
| Quince Therapeutics, Inc. | 95.12 Million USD | -922.38% |
| Rezolute, Inc. | 11.73 Million USD | -8187.779% |
| Clene Inc. | 38.95 Million USD | -2396.696% |
| Indaptus Therapeutics, Inc. | 2.84 Million USD | -34053.783% |
| BeyondSpring Inc. | 48.26 Million USD | -1914.726% |
| Synlogic, Inc. | 32.89 Million USD | -2856.34% |
| Allarity Therapeutics, Inc. | 14.61 Million USD | -6554.951% |
| Phio Pharmaceuticals Corp. | 1.63 Million USD | -59415.789% |
| Peak Bio, Inc. | 20.75 Million USD | -4585.929% |
| Werewolf Therapeutics, Inc. | 63.45 Million USD | -1432.467% |
| Krystal Biotech, Inc. | 39.71 Million USD | -2348.728% |
| Karyopharm Therapeutics Inc. | 376.64 Million USD | -158.198% |
| SpringWorks Therapeutics, Inc. | 99.56 Million USD | -876.698% |
| Lipella Pharmaceuticals Inc. | 432.72 Thousand USD | -224635.283% |
| MannKind Corporation | 721.36 Million USD | -34.812% |
| Ikena Oncology, Inc. | 22.33 Million USD | -4254.099% |
| Cyclerion Therapeutics, Inc. | 2.08 Million USD | -46519.751% |
| Gyre Therapeutics, Inc. | 102.59 Million USD | -847.936% |
| Gossamer Bio, Inc. | 249.14 Million USD | -290.327% |
| CohBar, Inc. | 1.03 Million USD | -93984.002% |
| Cognition Therapeutics, Inc. | 10.68 Million USD | -8998.026% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -5005.46% |
| Legend Biotech Corporation | 589.93 Million USD | -64.847% |
| Mural Oncology plc | 37.92 Million USD | -2464.037% |
| Biora Therapeutics, Inc. | 132.63 Million USD | -633.201% |
| PaxMedica, Inc. Common Stock | 2.29 Million USD | -42268.076% |
| Disc Medicine, Inc. | 22.87 Million USD | -4151.314% |
| Champions Oncology, Inc. | 28.03 Million USD | -3368.835% |
| REGENXBIO Inc. | 262.22 Million USD | -270.856% |
| Ensysce Biosciences, Inc. | 3.35 Million USD | -28848.678% |
| Anavex Life Sciences Corp. | 12.53 Million USD | -7658.8% |
| Cellectar Biosciences, Inc. | 13.43 Million USD | -7140.284% |
| Edgewise Therapeutics, Inc. | 21.2 Million USD | -4486.126% |
| Vaxart, Inc. | 34.02 Million USD | -2758.157% |
| PharmaCyte Biotech, Inc. | 20.38 Million USD | -4669.608% |
| Aldeyra Therapeutics, Inc. | 28.53 Million USD | -3308.426% |
| Cellectis S.A. | 249.57 Million USD | -289.658% |
| Longeveron Inc. | 5.33 Million USD | -18121.623% |
| Repare Therapeutics Inc. | 41.81 Million USD | -2225.469% |
| Sarepta Therapeutics, Inc. | 2.4 Billion USD | 59.568% |
| Inozyme Pharma, Inc. | 60.36 Million USD | -1510.933% |
| Revolution Medicines, Inc. | 262.39 Million USD | -270.617% |
| Nymox Pharmaceutical Corporation | 2.1 Million USD | -46055.102% |
| Third Harmonic Bio, Inc. | 8.62 Million USD | -11173.916% |
| ArriVent BioPharma, Inc. Common Stock | 11.8 Million USD | -8140.725% |
| AN2 Therapeutics, Inc. | 14.04 Million USD | -6825.073% |
| Anixa Biosciences, Inc. | 2.15 Million USD | -45110.972% |
| Vertex Pharmaceuticals Incorporated | 5.14 Billion USD | 81.116% |
| Denali Therapeutics Inc. | 122.96 Million USD | -690.879% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -17375.409% |
| Veru Inc. | 32.81 Million USD | -2863.754% |
| Corvus Pharmaceuticals, Inc. | 6.86 Million USD | -14057.636% |
| Cingulate Inc. | 10.36 Million USD | -9286.166% |
| Passage Bio, Inc. | 39.26 Million USD | -2376.919% |
| Context Therapeutics Inc. | 4.19 Million USD | -23100.241% |
| Exicure, Inc. | 8.54 Million USD | -11275.459% |
| Day One Biopharmaceuticals, Inc. | 29.5 Million USD | -3195.676% |
| Oramed Pharmaceuticals Inc. | 10.48 Million USD | -9174.156% |
| Scinai Immunotherapeutics Ltd. | 22.04 Million USD | -4312.177% |
| Rhythm Pharmaceuticals, Inc. | 162.98 Million USD | -496.67% |
| Nuvalent, Inc. | 31.82 Million USD | -2955.928% |
| ABVC BioPharma, Inc. | 6.36 Million USD | -15186.781% |
| Carisma Therapeutics, Inc. | 63.02 Million USD | -1443.093% |
| Unicycive Therapeutics, Inc. | 18 Million USD | -5302.711% |
| OmniAb, Inc. | 87.4 Million USD | -1012.686% |
| Anew Medical, Inc. | 8.24 Million USD | -11699.463% |
| Fennec Pharmaceuticals Inc. | 38.28 Million USD | -2439.856% |
| Lipocine Inc. | 2.63 Million USD | -36853.841% |
| Lexeo Therapeutics, Inc. Common Stock | 26.27 Million USD | -3601.614% |
| Nautilus Biotechnology, Inc. | 40.21 Million USD | -2318.402% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -3550.232% |
| G1 Therapeutics, Inc. | 86.15 Million USD | -1028.779% |
| Bellerophon Therapeutics, Inc. | 5.4 Million USD | -17905.703% |
| Sage Therapeutics, Inc. | 82.74 Million USD | -1075.255% |
| Ocugen, Inc. | 23.98 Million USD | -3954.906% |
| Mind Medicine (MindMed) Inc. | 46.4 Million USD | -1995.563% |
| Q32 Bio Inc. | 233.12 Million USD | -317.148% |
| Brainstorm Cell Therapeutics Inc. | 9.06 Million USD | -10626.759% |
| Alumis Inc. Common Stock | 53.5 Million USD | -1717.667% |
| Equillium, Inc. | 27.95 Million USD | -3378.513% |
| Kyverna Therapeutics, Inc. | 206.59 Million USD | -370.729% |
| Coya Therapeutics, Inc. | 5.62 Million USD | -17183.56% |
| CNS Pharmaceuticals, Inc. | 6.13 Million USD | -15756.727% |
| Galera Therapeutics, Inc. | 157.32 Million USD | -518.136% |
| Evelo Biosciences, Inc. | 69.43 Million USD | -1300.614% |
| Comera Life Sciences Holdings, Inc. | 9.97 Million USD | -9650.034% |
| Dominari Holdings Inc. | 4.63 Million USD | -20881.402% |
| Edesa Biotech, Inc. | 1.84 Million USD | -52705.629% |
| vTv Therapeutics Inc. | 29.56 Million USD | -3189.099% |
| Bio-Techne Corporation | 744.34 Million USD | -30.651% |
| Agios Pharmaceuticals, Inc. | 126.09 Million USD | -671.21% |
| Harmony Biosciences Holdings, Inc. | 344.45 Million USD | -182.326% |
| Prelude Therapeutics Incorporated | 40.57 Million USD | -2296.766% |
| Candel Therapeutics, Inc. | 28.95 Million USD | -3258.387% |
| iTeos Therapeutics, Inc. | 92.36 Million USD | -952.932% |
| Nkarta, Inc. | 105.6 Million USD | -820.917% |
| BioCardia, Inc. | 4.59 Million USD | -21087.102% |
| Iterum Therapeutics plc | 32.66 Million USD | -2877.429% |